The use of kidneys with small renal tumors for transplantation: Who is taking the risk?

American Journal of Transplantation

Volumn 12, Issue 1, 2012, Pages 48-54

  Flechner, S M ^a   Campbell, S C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Deceased donor; kidney cancer; living kidney donor; renal mass

Indexed keywords

CANCER DIAGNOSIS; CANCER SURVIVAL; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; KIDNEY TUMOR; METASTASIS; NEPHRECTOMY; NEPHRON SPARING SURGERY; PRIORITY JOURNAL; REVIEW; SURGICAL RISK; TREATMENT OUTCOME; TUMOR ABLATION;

HUMANS; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; LIKELIHOOD FUNCTIONS; NEOPLASM METASTASIS; RISK ASSESSMENT;

EID: 84855932939     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03794.x     Document Type: Review

References (37)

1. The Organ Procurement and Transplant Network. Accessed July 8, 2011.
2. Nicol D, Preston J, Wall D, et al,. Kidneys from patients with small renal tumours: A novel source of kidneys for transplantation. BJU Int 2008; 102: 188-193.
3. Mannami M, Mannami R, Mitsuhata N, et al,. Last resort for renal transplant recipients, 'restored' kidneys from living donors/patients. Am J Transplant 2008; 8: 811-818. (Pubitemid 351347755)
4. McDermott K, Delriviere L, Bulang He, et al,. A source for over 3000 additional kidney transplants per year in the US. Am J Transplant 2011; 11: 135 (Abstract 346).
5. Rini BI, Campbell SC, Escudier B,. Renal cell carcinoma. Lancet 2009; 373: 1119-1132.
6. Luciani LG, Cestari R, Tallarigo C,. Incidental renal cell carcinoma, stage characterization, and clinical implications: Study of 1092 patients. Urology 2000; 56: 58-62. (Pubitemid 30408654)
7. Frank I, Blute M, Cheville JC, et al,. Solid renal tumors: An analysis of pathologic features related to tumor size. J Urology 2003; 170: 2217-2220. (Pubitemid 37413960)
8. Pahernick S, Ziegler S, Roos F, et al,. Small renal tumors: Correlation of clinical and pathological features with tumor size. J Urology 2007; 178: 414-417. (Pubitemid 47030507)
9. Lane B, Babineau D, Kattan M, et al,. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urology 2007; 178: 429-434. (Pubitemid 47030487)
10. Chawla SN, Crispen P, Hanlon A, et al,. The natural history of observed enhancig renal masses: Meta-analysis and review of the world literature. J Urology 2006; 175: 425-431. (Pubitemid 43067318)
11. Crispen P, Viterbo R, Boorjian S, et al,. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer 2009; 115: 2844-2852.
12. Liu L, Qian J, Singh H, et al,. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: An optimal and practical panel for differential diagnosis. Arch Pathol Lab Med 2007; 131: 190-197.
13. Uzzo R, Novick AC,. Nephron sparing surgery for renal tumors: Indications, techniques and outcomes. J Urol 2001; 166: 6-11.
14. Russo P, Huang W,. The medical and oncological rationale for partial nephrectomy for the treatment of T1 renal cortical tumors. Urol Clin North Amer 2008; 35: 635-643.
15. Huang WC, Levey AS, Serio AM, et al,. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: A retrospective cohort study. Lancet Oncol 2006; 7: 735-740. (Pubitemid 44283660)
16. Gill IS, Kavoussi LR, Lane BR, et al,. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007; 178: 41-46. (Pubitemid 46898481)
17. Rogers C, Sukumar S, Gill I,. Robotic partial nephrectomy: The real benefit. Curr Opin Urol 2011; 21: 60-64.
18. Sterret S, Nakada S, Wingo M, et al,. Renal thermal ablative therapy. Urol Clin North Amer 2008; 35: 397-414.
19. Aron M, Kamoi K, Remer E, et al,. Laparoscopic renal cryoablation: 8-year outcomes. J Urology 2010; 183: 889-895.
20. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY,. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
21. Fried LF, Katz R, Sarnak MJ, et al,. Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 2005; 16: 3728-3735. (Pubitemid 46211295)
22. Thompson R, Boorjian S, Lohse C, et al,. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urology 2008; 179: 468-471.
23. McKiernan J, Simmons R, Katz J, et al,. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 2002; 59: 816-820. (Pubitemid 34522166)
24. Thompson R, Boorjian S, Lohse C, et al,. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urology 2008; 179: 468-471.
25. Weight C, Larson B, Fergany, et al,. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death form any cause in patients with localized T1B renal masses. J Urology 2010; 183: 1317-1323.
26. Campbell SC, Novick A, Belldegrun A, et al,. Guideline for management of the clinical T1 renal mass. J Urology 2009; 182: 1271-1279.
27. Cooperberg MR, Malin K, Kane C, Carroll PR,. Treatment trends for stage I renal cell carcinoma. J Urology 2011; 186: 394-399.
28. Watson CJ, Roberts R, Wright KA, et al,. How safe is it to transplant organs from deceased donors with primary intracranial malignancy? An analysis of UK Registry data. Am J Transplant 2010; 10: 1437-1444.
29. Nalesnik MA, Woodle S, DiMaio JM, et al,. Donor transmitted malig- nancies in organtransplantation: Assessment of clinical risk. Am J Transplant 2011; 11: 1140-1147.
30. Buell JF, Hanawway MT, Munda R, et al,. Donor kidneys with small renal cell cancers: Can they be transplanted? Transplant Proc 2005; 37: 581-582. (Pubitemid 40590632)
31. CMS COP42 CFR Part 405, 482, 488, and 498. Fed Reg 2007; 72.
32. Sener A, Uberoi V, Bartlett S, et al,. Living-donor renal transplantation of grafts with incidental renal masses after ex-vivo partial nephrectomy. BJU Int 2009; 104: 1655-1660.
33. Cohen JA, Englesbe M, Wolf JS,. Can urologic oncologists help expand the renal donor pool with 'restored' kidneys? Urol Oncol 2008; 26: 573-574.
34. Wiklund F, Tretli S, Choueiri TK, et al,. Risk of bilateral renal cell cancer. J Clin Oncol 2009; 27: 3737-3741.
35. Rabbani F, Herr HW, Almahmeed T, Russo P,. Temporal change in risk of metachronous contralateral renal cell carcinoma: Influence of tumor characteristics and demographic factors. J Clin Oncol 2002; 20: 2370-2375. (Pubitemid 34441666)
36. Cox A, Nguan C, Luke P,. Partial nephrectomy for renal cell carcinoma in long-term renal allografts: Operative and post-operative considerations. Can J Urol 2005; 12: 2887-2890.
37. Barama A, St-Louis G, Nicolet V, et al,. Renal cell carcinoma in kidney allografts: A case series from a single center. Am J Transplant 2005; 5: 3015-3018. (Pubitemid 43923965)